AnchorDx ropes in $40m Series C
AnchorDx, a Chinese developer of DNA methylation NGS products, has raised $40 million in Series C financing.
AnchorDx, a Chinese developer of DNA methylation NGS products, has raised $40 million in Series C financing.
Copyright PEI Media
Not for publication, email or dissemination